Showing results (281-290 of 534) with videos related to
Sort By:
Pageof 54
JAMA|November 13, 2004
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trialSteven E Nissen, E Murat Tuzcu, Peter Libby, et al.Health Affairs (Project Hope)|September 16, 2005
Functional gaps in attaining a national health information networkRainu Kaushal, David W Bates, Eric G Poon, et al.The American Journal of Cardiology|July 28, 2004
Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary interventionDeepak P Vivekananthan, Deepak L Bhatt, Derek P Chew, et al.Issue Brief (Commonwealth Fund)|April 28, 2017
How Medicaid Enrollees Fare Compared with Privately Insured and Uninsured Adults: Findings from the Commonwealth Fund Biennial Health Insurance Survey, 2016Munira Z Gunja, Sara R Collins, David Blumenthal, et al.Health Affairs (Project Hope)|March 7, 2012
The need to incorporate health information technology into physicians' education and professional developmentPierce Graham-Jones, Sachin H Jain, Charles P Friedman, et al.American Heart Journal|January 6, 2005
Impact of female sex on outcome after percutaneous coronary interventionJohn H Chiu, Deepak L Bhatt, Khaled M Ziada, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 2005
Platelet, not endothelial, P-selectin is required for neointimal formation after vascular injuryKai Wang, Xiaorong Zhou, Zhongmin Zhou, et al.European Heart Journal|October 11, 2005
Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary interventionPeter R Sinnaeve, John Simes, Salim Yusuf, et al.The American Journal of Cardiology|March 11, 2005
Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical centerHitinder S Gurm, Vivek Rajagopal, Robert Fathi, et al.The American Journal of Cardiology|March 11, 2005
Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stentingAlbert W Chan, Jay S Yadav, Deepak L Bhatt, et al.Pageof 54